Susquehanna International Group, LLP Glycomimetics Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	BUY	$0.24 - $3.04 $193,824 - $2.46 Million	807,600 Added 222.72%	1,170,200 $327,000
Q1 2024 May 07, 2024	BUY	$2.55 - $3.49 $755,565 - $1.03 Million	296,300 Added 446.91%	362,600 $1.09 Million
Q4 2023 Feb 14, 2024	SELL	$1.13 - $2.54 $186,675 - $419,608	-165,200 Reduced 71.36%	66,300 $156,000
Q3 2023 Nov 14, 2023	BUY	$1.29 - $1.73 $162,282 - $217,634	125,800 Added 119.02%	231,500 $347,000
Q2 2023 Aug 11, 2023	BUY	$1.21 - $2.08 $48,400 - $83,200	40,000 Added 60.88%	105,700 $183,000
Q1 2023 May 16, 2023	BUY	$1.25 - $4.05 $50,000 - $162,000	40,000 Added 155.64%	65,700 $82,000
Q4 2022 Feb 14, 2023	BUY	$0.57 - $3.03 $14,648 - $77,871	25,700 New	25,700 $77,000
Q2 2022 Aug 15, 2022	SELL	$0.54 - $1.15 $16,092 - $34,270	-29,800 Reduced 32.68%	61,400 $37,000
Q1 2022 May 16, 2022	BUY	$1.0 - $1.58 $54,400 - $85,952	54,400 Added 147.83%	91,200 $104,000
Q4 2021 Feb 14, 2022	SELL	$1.44 - $2.14 $59,184 - $87,954	-41,100 Reduced 52.76%	36,800 $53,000
Q3 2021 Nov 15, 2021	SELL	$1.8 - $2.39 $124,560 - $165,388	-69,200 Reduced 47.04%	77,900 $171,000
Q2 2021 Aug 11, 2021	BUY	$2.16 - $3.18 $290,952 - $428,346	134,700 Added 1086.29%	147,100 $341,000
Q1 2021 May 17, 2021	SELL	$2.89 - $4.22 $15,606 - $22,788	-5,400 Reduced 30.34%	12,400 $37,000
Q3 2020 Nov 16, 2020	BUY	$3.07 - $5.0 $20,876 - $34,000	6,800 Added 61.82%	17,800 $55,000
Q2 2020 Aug 14, 2020	SELL	$2.06 - $3.76 $13,184 - $24,064	-6,400 Reduced 36.78%	11,000 $41,000
Q1 2019 May 15, 2019	BUY	$9.96 - $13.44 $173,304 - $233,856	17,400 New	17,400 $217,000
Q4 2018 Feb 14, 2019	SELL	$8.47 - $14.71 $293,062 - $508,966	-34,600 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$13.7 - $17.12 $613,760 - $766,976	-44,800 Reduced 56.42%	34,600 $498,000
Q2 2018 Aug 14, 2018	SELL	$14.63 - $19.19 $3.53 Million - $4.63 Million	-241,300 Reduced 75.24%	79,400 $1.28 Million
Q1 2018 May 15, 2018	BUY	$16.06 - $25.35 $4.54 Million - $7.16 Million	282,600 Added 741.73%	320,700 $5.21 Million
Q4 2017 Feb 14, 2018	BUY	$10.51 - $17.22 $400,431 - $656,082	38,100	38,100 $640,000

Others Institutions Holding GLYC

# of Institutions

Shares Held

17.8M

Call Options Held

Put Options Held

View Full List

About GLYCOMIMETICS INC

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $12.1M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

More about GLYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account